A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants

NCT03501069 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped Business Decision; no human safety concern; evaluating preclinical toxicology finding

Conditions

Interventions

Sponsor

Millennium Pharmaceuticals, Inc.